CTNM
Contineum Therapeutics, Inc.
13.20$
+3.5%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.9% | 97.9% | 96.9% | 99.5% | 99.6% | 97.0% | 96.9% | 96.7% | 96.9% | 96.8% | 96.8% | 96.9% | |
| 12.6% | 11.9% | 13.2% | 34.9% | 18.9% | 10.3% | 11.3% | 11.4% | 22.3% | 27.3% | 7.7% | 5.9% | |
| 97.2% | 96.0% | 95.4% | 98.8% | 99.0% | 96.2% | 96.2% | 96.0% | 95.6% | 95.0% | 94.3% | 94.5% | |
| 144.0% | 152.1% | 161.2% | 1.7% | 2.7% | 6.9% | 6.8% | 6.3% | 5.4% | 5.7% | 4.3% | 4.3% | |
| 5.3% | 4.2% | 5.0% | 1.7% | 2.7% | 4.7% | 4.5% | 3.9% | 3.3% | 3.5% | 2.5% | 2.6% | |
| 0.8% | 0.4% | 0.4% | 0.2% | 0.3% | 0.7% | 0.7% | 0.8% | 0.8% | 0.8% | 0.9% | 1.0% | |
| 0.8% | 0.5% | 0.5% | 0.3% | 0.6% | 0.9% | 1.8% | 1.1% | 0.4% | 0.4% | 0.6% | 0.2% | |
| -44.0% | -52.1% | -61.2% | 98.3% | 97.3% | 93.1% | 93.2% | 93.7% | 94.6% | 94.3% | 95.7% | 95.7% | |
| -48.5% | -57.6% | -67.6% | -41.8% | -47.6% | -55.2% | -67.3% | -81.7% | -85.0% | -64.1% | -73.4% | -82.7% | |
| 18.1% | 19.3% | 20.8% | 11.6% | 11.9% | 12.1% | 13.0% | 14.2% | 14.7% | 11.2% | 14.3% | 15.0% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.